Does TENOFOVIR ALAFENAMIDE Cause Low density lipoprotein increased? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Low density lipoprotein increased have been filed in association with TENOFOVIR ALAFENAMIDE (VEMLIDY). This represents 0.3% of all adverse event reports for TENOFOVIR ALAFENAMIDE.
9
Reports of Low density lipoprotein increased with TENOFOVIR ALAFENAMIDE
0.3%
of all TENOFOVIR ALAFENAMIDE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Low density lipoprotein increased From TENOFOVIR ALAFENAMIDE?
Of the 9 reports.
Is Low density lipoprotein increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TENOFOVIR ALAFENAMIDE. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does TENOFOVIR ALAFENAMIDE Cause?
Death (217)
Product dose omission issue (153)
Off label use (96)
Drug ineffective (93)
Fatigue (92)
Headache (71)
Product dose omission (69)
Intentional dose omission (67)
Product use issue (67)
Nausea (64)
What Other Drugs Cause Low density lipoprotein increased?
EVOLOCUMAB (1,024)
INCLISIRAN (423)
ALIROCUMAB (336)
ROSUVASTATIN (241)
ATORVASTATIN (217)
EZETIMIBE (217)
LOMITAPIDE (164)
TOFACITINIB (135)
FINGOLIMOD (132)
SOMATROPIN (93)
Which TENOFOVIR ALAFENAMIDE Alternatives Have Lower Low density lipoprotein increased Risk?
TENOFOVIR ALAFENAMIDE vs TENOFOVIR DISOPROXIL
TENOFOVIR ALAFENAMIDE vs TEPLIZUMAB-MZWV
TENOFOVIR ALAFENAMIDE vs TEPOTINIB
TENOFOVIR ALAFENAMIDE vs TEPROTUMUMAB
TENOFOVIR ALAFENAMIDE vs TEPROTUMUMAB-TRBW